Trend Results : "Prostate Cancer"


Blog Post Results (1-20 of 3159)

FILTER RESULTS

Coping with active surveillance anxiety in prostate cancer

Men with prostate cancer who are under medical surveillance reported significantly greater resilience and less anxiety after receiving an intervention of mindfulness meditation, a study found. The anxiety and uncertainty that men who...Show More Summary

Researcher Selected as 2016 Texas Inventor of the Year for His Breakthrough Treatments for Breast and Prostate Cancer

Marc Cox, Ph.D., associate professor in The University of Texas at El Paso's Department of Biological Sciences, has been selected as the 2016 Texas Inventor of the Year for his treatments for breast and prostate cancer developed at UTEP.

Differences in metabolism between androgen-dependent, castration resistant prostate cancer may lead to new therapies

Integration of gene expression and metabolomics data identified key metabolic pathways that are altered in prostate cancer, report scientists at conclusion of their study.

Differences in metabolism between androgen-dependent and castration resistant prostate cancer may lead to new therapies

Advanced prostate cancer is usually treated by removing androgen, the male hormone that helps it grow. Although initially effective, this treatment often leads to the tumor becoming castration resistant- a lethal condition. Researchers...Show More Summary

I’M NOT SAYING THIS IS A BAD IDEA, BUT I’M SUSPICIOUS THAT THEY ONLY STARTED TOUTING STUFF LIKE THIS…

I’M NOT SAYING THIS IS A BAD IDEA, BUT I’M SUSPICIOUS THAT THEY ONLY STARTED TOUTING STUFF LIKE THIS ONCE OBAMACARE PASSED: More Men With Early Prostate Cancer Choosing to Avoid Treatment. Seemingly overnight, treatment of men with early-stage prostate cancer has undergone a sea change. Five years ago, nearly all opted for surgery or […]

Active surveillance for prostate cancer: Comments, context and quips on The Times’ front-page coverage

Kevin Lomangino is the managing editor of HealthNewsReview.org. He tweets as @klomangino. The New York Times today had a front-page story noting that growing numbers of men diagnosed with prostate cancer are opting for active surveillance of their cancer rather than more aggressive surgery or radiation. Show More Summary

More Men With Early Prostate Cancer Choosing to Avoid Treatment

The approach, called active surveillance, involves regular monitoring. Data finds that 40 percent to 50 percent of men are making that choice.

Exercise: Future anticancer therapy?

The results are in from the first international clinical trial evaluating the effect of intense physical exercise to improve survival of men with advanced prostate cancer.

Exercise, future anticancer therapy?

Montreal (Quebec), May 24, 2016 - At age 70, Alfred Roberts plays hockey twice a week. Nothing special, right? Except that for three years he has had advanced prostate cancer, which has spread to his bones. "I've always been active. Hockey keeps me in shape and keeps my mind off things. Show More Summary

This Biotech Company Wants the Power to Deny Patients Access to Their Own Genetic Information

Myriad Genetics has already provoked ire for its former monopoly on testing for genes associated with breast, ovarian and prostate cancer. The biotechnology company Myriad Genetics is infamous for patenting the BRCA1 and BRCA2 genes—which...Show More Summary

The New Old Age: Older Men Are Still Being Overtested for Prostate Cancer

Eight years after an expert task force recommended against routine use of PSA screening for men over 75, testing levels have fallen only slightly.

In Obese Prostate Cancer Patients, Robotic Surgery Reduces Risk of Blood Loss and Prolonged Hospital Stays

In obese prostate cancer patients, robotic-assisted surgery to remove the prostate reduces the risk of blood loss and prolonged hospital stays, a Loyola Medicine study has found.

In obese prostate cancer patients, robotic surgery reduces risk of blood loss

MAYWOOD, IL. -- In obese prostate cancer patients, robotic-assisted surgery to remove the prostate reduces the risk of blood loss and prolonged hospital stays, a Loyola Medicine study has found. The study by senior author Gopal Gupta, MD and colleagues is published in the journal Current Urology. Show More Summary

A Way to Cut into CRPC and AML

Prostate cancer is the second leading cause of mortality among American men with the highest incidence rate of all cancers reported in the U.S. Research on this topic was presented at the AAPS National Biotechnology Conference.

The Nation's Top Doctors Converge to Discuss Cancer and Smoking Cessation

The care and management of patients who have been diagnosed with colon and prostate cancer requires a defined multidisciplinary approach. It requires out of the box treatment and an open mind because no two cases or diagnoses are the...Show More Summary

Defective 'breast cancer' genes aren't just dangerous for women. They're also linked to aggressive cancer in men.

last weekHealth : The Checkup

Mutations in BRCA1 and BRCA2 have well-established links to women's diseases -- breast and ovarian cancer. But they also elevate men's health risks, especially for prostate cancer.

Fueling the Force Against the Number One Cancer Killer

Lung cancer kills more people each year than breast, colon, pancreatic and prostate cancer combined. And, every eight minutes, a woman in the United States loses her battle with lung cancer. It's a silent health care crisis that is projected to end the lives of 72,000 American women in 2016 alone - more than a quarter of all female cancer deaths. Show More Summary

Genetic Biomarker May Predict Nerve Pain Side Effects Associated with Prostate Cancer Treatment, Moffitt Researchers Say

Taxanes are a group of drugs commonly used to treat cancers of the breast, lung, ovary, or prostate, but its use can be limited by significant side effects. Researchers from Moffitt Cancer Center report prostate cancer patients who have a variation in the VAC14 gene are more susceptible to a side effect called peripheral neuropathy when treated with the taxane docetaxel.

Quality of life meets cure for prostate cancer treatment

ANN ARBOR, Mich. -- Remember the game Operation? You need to carefully remove the body part without nicking the sides or the buzzer will sound. Only imagine pulling out the funny bone when it's surrounded by vessels controlling urinary and sexual function. Show More Summary

New PSA test examines protein structures to detect prostate cancers

Tuesday, May 10, 2016, San Diego: A promising new test is detecting prostate cancer more precisely than current tests, by identifying molecular changes in the prostate specific antigen (PSA) protein, according to Cleveland Clinic research...Show More Summary

Copyright © 2015 Regator, LLC